Astrazeneca Plc Earnings

Astrazeneca Plc’s revenue jumped 11.99% since last year same period to $15191Mn in the Q3 2025. On a quarterly growth basis, Astrazeneca Plc has generated 5.08% jump in its revenue since last 3-months.

Astrazeneca Plc’s net profit jumped 77.26% since last year same period to $2533Mn in the Q3 2025. On a quarterly growth basis, Astrazeneca Plc has generated 3.39% jump in its net profits since last 3-months.

Astrazeneca Plc’s net profit margin jumped 58.28% since last year same period to 16.67% in the Q3 2025. On a quarterly growth basis, Astrazeneca Plc has generated -1.61% fall in its net profit margins since last 3-months.

Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 1.09 - a -4.39% fall from last quarter’s estimates.

Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 1.09.

Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.